» Articles » PMID: 35117526

Correlation Analysis of Multi-slice Computed Tomography (MSCT) Findings, Clinicopathological Factors, and Prognosis of Gastric Gastrointestinal Stromal Tumors

Overview
Specialty Oncology
Date 2022 Feb 4
PMID 35117526
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Computed tomography (CT) findings and clinicopathological characteristics of gastric gastrointestinal stromal tumors (GISTs) have been reported in the past, however, studies on their association with prognosis are limited. We aimed to evaluate the correlation between multi-slice computed tomography (MSCT) findings and clinicopathological characteristics for the prognosis of gastric GISTs. Multiple independent factors influencing the prognostic assessment of gastric GISTs were recognized.

Methods: The CT images and clinicopathological data of 155 patients with gastric GISTs were retrospectively analyzed. Progression-free survival of patients was obtained using the Kaplan-Meier method and compared using the log-rank test. Univariate and multivariate analyses were performed to evaluate the prognostic significance of CT imaging and clinicopathological factors.

Results: Univariate analysis revealed that patient prognosis was associated with the size, shape, necrosis or cystic degeneration, margin, growth pattern, enhancement pattern, mitotic rate, and Ki-67 index of the tumor. Further, multivariate analysis indicated that tumor size and necrosis or cystic degeneration were significant independent prognostic factors for gastric GISTs.

Conclusions: Tumor shape, necrosis or cystic degeneration, growth pattern, enhancement pattern, and mitotic rate were non-negligible criteria for improving the prognostic accuracy for GISTs, whereas tumor size, margin, and Ki-67 index were significant independent predictors identifying high-risk patients, facilitating personalized treatment to improve the prognosis of gastric GISTs patients. Thus, a combination of MSCT findings and clinicopathological features may be a valuable tool for assessing the prognosis of patients with gastric GISTs.

Citing Articles

Convolutional neural network applied to preoperative venous-phase CT images predicts risk category in patients with gastric gastrointestinal stromal tumors.

Wang J, Shao M, Hu H, Xiao W, Cheng G, Yang G BMC Cancer. 2024; 24(1):280.

PMID: 38429653 PMC: 10908217. DOI: 10.1186/s12885-024-11962-y.


Relationship between multi-slice computed tomography features and pathological risk stratification assessment in gastric gastrointestinal stromal tumors.

Wang T, Liu W, Liu X, Gao R, Zhu C, Wang Q World J Gastrointest Oncol. 2023; 15(6):1073-1085.

PMID: 37389110 PMC: 10303000. DOI: 10.4251/wjgo.v15.i6.1073.


Early Prediction and Monitoring of Treatment Response in Gastrointestinal Stromal Tumors by Means of Imaging: A Systematic Review.

Weeda Y, Kalisvaart G, van Velden F, Gelderblom H, van der Molen A, Bovee J Diagnostics (Basel). 2022; 12(11).

PMID: 36359564 PMC: 9689665. DOI: 10.3390/diagnostics12112722.


Gastrointestinal stromal tumors: associations between contrast-enhanced CT images and KIT exon 11 gene mutation.

Liu X, Yin Y, Wang X, Yang C, Wan S, Yin X Ann Transl Med. 2021; 9(19):1496.

PMID: 34805358 PMC: 8573436. DOI: 10.21037/atm-21-3811.

References
1.
Nishida T, Sakai Y, Takagi M, Ozaka M, Kitagawa Y, Kurokawa Y . Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world. Gastric Cancer. 2019; 23(1):118-125. PMC: 6942594. DOI: 10.1007/s10120-019-00966-4. View

2.
Buscheck F, Sulimankhil M, Melling N, Hoflmayer D, Hube-Magg C, Simon R . Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients. Cancer Med. 2020; 9(4):1409-1418. PMC: 7013067. DOI: 10.1002/cam4.2773. View

3.
Faiyaz-Ul-Haque M, Al-Dayel F, Tulba A, AbalKhail H, Alhussaini H, Memon M . Spectrum of the KIT Gene Mutations in Gastrointestinal Stromal Tumors in Arab Patients. Asian Pac J Cancer Prev. 2018; 19(10):2905-2910. PMC: 6291029. DOI: 10.22034/APJCP.2018.19.10.2905. View

4.
Joensuu H . Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol. 2008; 39(10):1411-9. DOI: 10.1016/j.humpath.2008.06.025. View

5.
Li P, Li M, Wang K, Liu Y, Wang Y, Zhao D . Genetic alterations in cell cycle regulation-associated genes may promote primary progression of gastrointestinal stromal tumors. Lab Invest. 2019; 100(3):426-437. DOI: 10.1038/s41374-019-0322-x. View